What is Alvee?
Alvee operates at the intersection of health technology and social care, providing an AI-driven platform designed to integrate SDOH data directly into clinical workflows. By automating the identification of social risks and streamlining documentation, the company enables healthcare providers, payers, and community organizations to deliver truly whole-person care. The platform is engineered to turn complex social care programs into measurable clinical and operational gains, facilitating compliant reimbursement and demonstrating the tangible impact of social interventions on patient health outcomes. Through its proprietary technology, Alvee is effectively operationalizing the social drivers of health, a critical component for modern value-based care models.
How much funding has Alvee raised?
Alvee has raised a total of $2.5M across 1 funding round:
Stock/Share Issuance
$2.5M
Stock/Share Issuance (2026): $2.5M, investors not publicly disclosed
Key Investors in Alvee
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Alvee?
With this major enterprise-level funding, Alvee is positioned to accelerate its product roadmap and expand its footprint across the healthcare ecosystem. The strategic focus will likely center on scaling its AI automation capabilities to handle larger datasets and deepening integrations with existing electronic health record systems. As the industry shifts toward more holistic care delivery, Alvee's ability to provide actionable insights from SDOH data will be instrumental in helping its clients navigate the complexities of value-based reimbursement. The company is expected to leverage this capital to bolster its market presence, enhance its technical infrastructure, and continue its trajectory as a leader in the health tech sector, ultimately driving better patient outcomes through data-informed social care strategies.
See full Alvee company page
